Clinical Outcomes in Elderly Patients with Advanced Non-small Cell Lung Cancer: Results from ARIES, a Bevacizumab Observational Cohort Study von Wozniak, A.J, Kosty, M.P, Jahanzeb, M, Brahmer, J.R, Spigel, D.R, Leon, L, Fish, S, Flick, E.D, Hazard, S.J, Lynch, T.J

Volltext

Safety and dose modification for patients with low body weight receiving niraparib in the ENGOT-OV16/NOVA phase III trial von Lord, R., Mirza, M.R., Woelber, L., Lesoin, A., Pineda, M.J., Peen, U., Hazard, S.J., Matulonis, U.A.

Volltext

Baseline platelet count and body weight as predictors of early dose modification in the quadra trial of niraparib monotherapy for the treatment of heavily pretreated (≥4th line), a... von Matulonis, U.A., Monk, B.J., Secord, A.A., Geller, M.A., Miller, D.S., Cloven, N.G., Fleming, G.F., Hendrickson, A.E. Wahner, Azodi, M., DiSilvestro, P.A., Oza, A.M., Cristea, M., Berek, J.S., Chan, J.K., Li, Y., Luptakova, K., Hazard, S.J., Moore, K.N.

Volltext

The exposure-response relationship of niraparib in patients with gBRCAmut and non-gBRCAmut: Results from the ENGOT-OV16/NOVA Trial von Wang, J., Zhang, Z-Y., Mirza, M.R., Gilbert, L., Fabbro, M., Tinker, A.V., Wang, X., Redondo, A., Berek, J.S., Woelber, L., Pentikis, H.S., Moore, K.N., Lorusso, D., Benigno, B., Hazard, S.J., Follana, P., Rimel, B.J., Matulonis, U.A., Agarwal, S., Kansra, V.

Volltext

Safety and Efficacy of Niraparib in Elderly Patients (Pts) with Recurrent Ovarian Cancer (OC) von Fabbro, M., Moore, K.N., Dørum, A., Tinker, A.V., Mahner, S., Bover, I., Banerjee, S., Tognon, G., Goffin, F., Shapira-Frommer, R., Wenham, R.M., Hellman, K., Provencher, D.M., Harter, P., Palacio Vázquez, I., Follana, P., Pineda, M.J., Mirza, M.R., Hazard, S.J., Matulonis, U.A.

Volltext

PARTICULES SCELLABLES A CHAUD ET TISSUS CONTENANT CES DERNIERS von S.J. HAZARD, E.W. MALCOLM

Volltext bestellen

PARTICULES COMPOSEES SCELLABLES A CHAUD POUR DES TISSUS A INFUSION ET PROCEDE DE PREPARATION von S.J. HAZARD, E.W. MALCOLM

Volltext bestellen

Neoadjuvant niraparib in patients with HER2-negative, BRCA-mutated resectable breast cancer von Spring, L.M., Han, H., Hamilton, E., Irie, H., Santa-Maria, C.A., Reeves, J., Pan, P., Shan, M., Tang, Y., Graham, J.R., Hazard, S., Ellisen, L.W., Isakoff, S.J.

Volltext

P095 - Neoadjuvant niraparib in patients with HER2-negative, BRCA-mutated resectable breast cancer von Spring, L.M., Han, H., Hamilton, E., Irie, H., Santa-Maria, C.A., Reeves, J., Pan, P., Shan, M., Tang, Y., Graham, J.R., Hazard, S., Ellisen, L.W., Isakoff, S.J.

Volltext

Subacute toxicity of dietary heptachlor to mink (Mustela vison) von AULERICH, R. J, BURSIAN, S. J, NAPOLITANO, A. C

Volltext